FIELD: immunology, biotechnology.
SUBSTANCE: described are rabies virus-neutralizing antibody and fragments thereof; method for treatment of subject being affected by rabies virus using said antibody and fragments thereof. Disclosed are variants of isolated nucleic acids, encoding polypeptides bearing light and/or heavy antibody strain, respectively. Disclosed is expression vector bearing at least one from abovementioned nucleic acids. The invention makes it possible to increase subject survival after rabies virus attack.
EFFECT: method for prophylaxis and treatment of rabies virus infections.
14 cl, 1 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
RABIES VIRUS-SPECIFIC HUMAN NEUTRALIZING MONOCLONAL ANTIBODY AND NUCLEIC ACID AND METHODS ASSOCIATED WITH THEREOF | 2001 |
|
RU2272809C2 |
HUMANISED 5D3HU ANTIBODY BINDING TO THE PRAME TUMOUR ANTIGEN, DNA FRAGMENTS ENCODING SAID ANTIBODY, AND ANTIGEN-BINDING FRAGMENT OF THE ANTIBODY | 2020 |
|
RU2761876C1 |
TUMOUR-TARGETED MONOCLONAL ANTIBODIES AGAINST FZD10 AND THEIR APPLICATION | 2006 |
|
RU2412203C2 |
NEUTRALIZING MONOCLONAL ANTIBODY BINDING TO RABIES VIRUS GLYCOPROTEIN G, DNA FRAGMENTS CODING SAID ANTIBODY, AND ANTIGEN-BINDING FRAGMENT | 2017 |
|
RU2718835C2 |
HUMANIZED ANTIBODY 6H8HU, BINDING TO TUMOUR ANTIGEN PRAME, DNA FRAGMENTS CODING SAID ANTIBODY AND ANTIGEN-BINDING ANTIBODY FRAGMENT | 2020 |
|
RU2768737C1 |
RECOMBINANT FUSION PROTEIN SPECIFICALLY BINDING AND NEUTRALIZING RABIES VIRUS, METHOD FOR PRODUCTION AND USE THEREOF | 2023 |
|
RU2829507C1 |
RECOMBINANT ANTIBODY IL4 USED FOR TREATMENT OF DISORDERS ASSOCIATED WITH FUNCTION OF IL4 | 1994 |
|
RU2162711C2 |
ANTIBODIES-ANTAGONISTS AGAINST Notch3 AND THEIR APPLICATION FOR PREVENTION AND TREATMENT OF Notch3-RELATED DISEASES | 2007 |
|
RU2493167C2 |
ANTIBODIES RAISED AGAINST α-INTERFERON | 2002 |
|
RU2314317C2 |
gp41-NEUTRALIZING ANTIBODIES AND THEIR APPLICATION | 2012 |
|
RU2624046C2 |
Authors
Dates
2007-01-27—Published
2002-08-21—Filed